249 related articles for article (PubMed ID: 10461022)
1. Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleus.
Bailey AR; Giles M; Brown CH; Bull PM; Macdonald LP; Smith LC; Smith RG; Leng G; Dickson SL
Neuroendocrinology; 1999 Aug; 70(2):83-92. PubMed ID: 10461022
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone-releasing hormone and morphine attenuate growth hormone secretagogue-induced activation of the arcuate nucleus in the male rat.
Bailey AR; Honda K; Smith RG; Leng G
Neuroendocrinology; 1999 Aug; 70(2):101-6. PubMed ID: 10461024
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway.
Bailey AR; von Engelhardt N; Leng G; Smith RG; Dickson SL
J Neuroendocrinol; 2000 Mar; 12(3):191-7. PubMed ID: 10718914
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action.
Dickson SL; Viltart O; Bailey AR; Leng G
Neuroendocrinology; 1997 Sep; 66(3):188-94. PubMed ID: 9380276
[TBL] [Abstract][Full Text] [Related]
5. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6.
Dickson SL; Luckman SM
Endocrinology; 1997 Feb; 138(2):771-7. PubMed ID: 9003014
[TBL] [Abstract][Full Text] [Related]
6. The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.
Bailey AR; Smith RG; Leng G
J Neuroendocrinol; 1998 Feb; 10(2):111-8. PubMed ID: 9535057
[TBL] [Abstract][Full Text] [Related]
7. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.
Tannenbaum GS; Bowers CY
Endocrine; 2001 Feb; 14(1):21-7. PubMed ID: 11322498
[TBL] [Abstract][Full Text] [Related]
8. Central actions of peptide and non-peptide growth hormone secretagogues in the rat.
Dickson SL; Leng G; Dyball RE; Smith RG
Neuroendocrinology; 1995 Jan; 61(1):36-43. PubMed ID: 7731496
[TBL] [Abstract][Full Text] [Related]
9. Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats.
Luckman SM; Rosenzweig I; Dickson SL
Neuroendocrinology; 1999 Aug; 70(2):93-100. PubMed ID: 10461023
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats.
Tamura H; Kamegai J; Shimizu T; Ishii S; Sugihara H; Oikawa S
Endocrinology; 2002 Sep; 143(9):3268-75. PubMed ID: 12193538
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
Kineman RD; Kamegai J; Frohman LA
Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus.
Minami S; Kamegai J; Sugihara H; Suzuki N; Wakabayashi I
Endocr J; 1998 Apr; 45 Suppl():S19-26. PubMed ID: 9790225
[TBL] [Abstract][Full Text] [Related]
13. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion.
Tannenbaum GS; Epelbaum J; Bowers CY
Endocrinology; 2003 Mar; 144(3):967-74. PubMed ID: 12586774
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons.
Zheng H; Bailey A; Jiang MH; Honda K; Chen HY; Trumbauer ME; Van der Ploeg LH; Schaeffer JM; Leng G; Smith RG
Mol Endocrinol; 1997 Oct; 11(11):1709-17. PubMed ID: 9328352
[TBL] [Abstract][Full Text] [Related]
15. Skeletal growth acceleration with growth hormone secretagogues in transgenic growth retarded rats: pattern-dependent effects and mechanisms of desensitization.
Wells T; Houston PA
J Neuroendocrinol; 2001 Jun; 13(6):496-504. PubMed ID: 11412336
[TBL] [Abstract][Full Text] [Related]
16. Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats.
Lee J; Kwon A; Chae HW; Lee WJ; Kim TH; Kim HS
Yonsei Med J; 2018 Dec; 59(10):1174-1180. PubMed ID: 30450851
[TBL] [Abstract][Full Text] [Related]
17. The effect of hypophysectomy and growth hormone replacement on sst1 and sst2 somatostatin receptor subtype messenger ribonucleic acids in the arcuate nucleus.
Guo F; Beaudet A; Tannenbaum GS
Endocrinology; 1996 Sep; 137(9):3928-35. PubMed ID: 8756568
[TBL] [Abstract][Full Text] [Related]
18. Central glucoprivation evoked by administration of 2-deoxy-D-glucose induces expression of the c-fos gene in a subpopulation of neuropeptide Y neurons in the rat hypothalamus.
Minami S; Kamegai J; Sugihara H; Suzuki N; Higuchi H; Wakabayashi I
Brain Res Mol Brain Res; 1995 Nov; 33(2):305-10. PubMed ID: 8750890
[TBL] [Abstract][Full Text] [Related]
19. Central actions of the nonpeptide growth hormone secretagogue GHS-25.
Bailey AR; Gilliver L; Leng G; Smith RG
Endocrine; 2001 Feb; 14(1):15-9. PubMed ID: 11322497
[TBL] [Abstract][Full Text] [Related]
20. GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6.
Dickson SL; Doutrelant-Viltart O; Leng G
J Endocrinol; 1995 Sep; 146(3):519-26. PubMed ID: 7595148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
